Clinical Trials Browser

Phase 2 × Testicular Germ Cell Tumor × Temozolomide × Clear all

NCT00006043 2013-06-05

Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin

Phase 2 Completed

GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms